Markets fall, Nifty, Sensex slip nearly 1 per cent: What’s worrying investors at the moment?

It’s been a worrying Wednesday for the market so far. Continuing with the volatile trend earlier this week, the indices have seen sharp correction in afternoon trade. The Nifty has slipped over a percent and is now trading around the 23,600 mark while the Sensex has breached the key 78000 mark. The continuous outflow of funds has been a source of worry but that apart there are some broad macro concerns for the indices too.

Macro worries for investors: Inflation at 14-month high, rate cut unlikely in Dec

The inflation reading for October came in at 14-month high. At 6.21%, the inflation print was significantly higher than expectations that were hovering under the key 6% mark. This is an outcome of a combination of factors. Starting with unfavourable base effects, vegetable prices at new highs, especially inion prices shooting to 5-month highs and also international palm oil prices inching upwards. According to JM Financial they see “upside risk of 40bps to RBI’s inflation expectation of 4.8% for Q3FY25. Markets are building in shallow rate cut cycle by the Fed. We believe RBI would avoid any premature policy moves and continue to focus on domestic macros over external events. We expect status quo in Dec’24.”

Even Dharmakirti Joshi, Chief Economist, CRISIL corroborated the view, “though non-food inflation remains benign around 3%, the recurring flare-up in food inflation has kept headline inflation elevated and creates an upside risk to the inflation trajectory – restricting the easing in monetary policy. We expect the Monetary Policy Committee (MPC) to hold rates steady in December, given the sharp rise in food inflation in September and October. That said, in our base case, we expect food inflation to ease this fiscal as kharif sowing has been healthy. Vegetable prices can correct sharply when fresh stocks enter the market. Accordingly, we expect the MPC to cut rates towards the end of this fiscal.”

Global cues

The Asian markets have closed on a weaker note in line with US markets that ended trade on Tuesday significantly weaker. The Nikkei shut ship down 1.69% while Hang Seng closed down 0.17%. The Dow closed nearly 300 points lower on Tuesday- November 12. The Chinese markets however bucked the trend driven by strong stimulus push by the Chinese Central Bank.

FII selling continues

Of course the continued fund outflow has been a worrying factor for the markets.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s